Dr Corey Giles is a Group Leader in the Metabolomics laboratory at the Baker Heart and Diabetes Institute. He leads a program of research focused on understanding the mechanisms through which lipid metabolism affects chronic diseases — including type 2 diabetes, cardiovascular disease, and Alzheimer’s disease. His career goals are to identify the metabolic pathways that play a causal role in disease aetiology.

Dysregulation of lipid metabolism is intimately linked to the aetiology, progression, and sequalae of many chronic diseases. Dr Giles’ research utilises state-of-the-art high throughput lipidomic profiling of clinical and population cohorts to define how environment and genetics influence lipid metabolism. Integrating lipidomic data with genomic resources opens new avenues for defining lipid species and pathways causally associated with disease aetiology and progression.

Supported by a dedicated and diverse research team — led by Professor Peter Meikle — Corey is developing and applying novel statistical techniques to a fast-growing collection of human lipidomes.